InMed Pharmaceuticals, Inc. (INM)
1.74
+0.13
(+8.07%)
USD |
NASDAQ |
May 21, 16:00
1.76
+0.02
(+1.15%)
After-Hours: 17:52
InMed Pharmaceuticals Cash from Investing (Quarterly) : 0.00 for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| CannaPharmaRx, Inc. | -0.0055M |
| Lexaria Bioscience Corp. | -0.0539M |
| Target Group, Inc. (Canada) | -0.0401M |
| Tilray Brands, Inc. | 28.63M |
| NervGen Pharma Corp. | 0.0061M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.759M |
| Cash from Financing (Quarterly) | 0.2315M |
| Free Cash Flow | -7.710M |
| Free Cash Flow Per Share (Quarterly) | -0.4345 |
| Free Cash Flow to Equity (Quarterly) | -1.647M |
| Free Cash Flow to Firm (Quarterly) | -1.759M |
| Free Cash Flow Yield | -127.0% |